p57(KIP2) expression and loss of heterozygosity during immortal conversion of cultured human mammary epithelial cells

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5112-5118

  Nijjar, Tarlochan ^a   Wigington, Don ^a   Garbe, James C ^a   Waha, Andreas ^b   Stampfer, Martha R ^a   Yaswen, Paul ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P57; RNA DIRECTED DNA POLYMERASE; TELOMERASE; UNCLASSIFIED DRUG; CDKN1C PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; DNA BINDING PROTEIN; ENZYME INHIBITOR; MESSENGER RNA; NUCLEAR PROTEIN; RNA; TELOMERASE RNA;

ARTICLE; BREAST EPITHELIUM; CELL CULTURE; CELL CYCLE G0 PHASE; CELL GROWTH; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RESTRICTION FRAGMENT; RETROVIRUS; TELOMERE; ALLELE; BREAST; CELL TRANSFORMATION; CHEMISTRY; EPITHELIUM CELL; GENETICS; PATHOLOGY; PHYSIOLOGY;

ALLELES; BREAST; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; NUCLEAR PROTEINS; RNA; RNA, MESSENGER; TELOMERASE; TELOMERE;

EID: 0032589743     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Campisi, J., Dimri, G., and Hara, E. Control of replicative senescence. In: E. L. Schneider and J. W. Rowe (eds.), Handbook of the Biology of Aging, pp. 121-149. San Diego, CA: Academic Press, 1996.
2. Henderson, S., Allsopp, R., Spector, D., Wang, S-S., and Harley, C. In situ analysis of changes in telomere size during replicative aging and cell transformation. J. Cell Biol., 134: 1-12, 1996.
3. Elledge, S. J., Winston, J., and Harper, J. W. A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol., 6: 388-392, 1996.
4. Winqvist, R., Mannermaa, A., Alavaikko, M., Blanco, G., Taskinen, P. J., Kiviniemi, H., Newsham, I., and Cavenee, W. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors. Cancer Res., 53: 4486-4488, 1993.
5. Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., and Elledge, S. J. p57KIP2, a structurally distinct member of the p21CIPI Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 9: 650-662, 1995.
6. Takita, K., Sato, T., Miyagi, M., Watatani, M., Akiyama, F., Sakamoto, G., Kasumi, F., Abe, R., and Nakamura, Y. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res., 52: 3914-3917, 1992.
7. Theillet, C., Lidereau, R., Escot, C., Hutzell, P., Brunet, M., Gest, J., Schlom, J., and Callahan, R. Loss of a c-ras-1 allele and aggressive human primary breast carcinomas. Cancer Res., 46: 4776-4781, 1986.
8. Karnik, P., Plummer, S., Casey, G., Myles, J., Tubbs, R., Crowe, J., and Williams, B. R. Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis. Hum. Mol. Genet., 4: 1889-1894, 1995.
9. Matsuoka, S., Thompson, J. S., Edwards, M. C., Barletta, J. M., Grundy, P., Kalikin, L. M., Harper, J. W., Elledge, S. J., and Feinberg, A. P. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc. Natl. Acad. Sci. USA, 93: 3026-3030, 1996.
10. Kondo, M., Matsuoka, S., Uchida, K., Osada, H., Nagatake, M., Takagi, K., Harper, J. W., Takahashi, T., Elledge, S. J., and Takahashi, T. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Oncogene, 12: 1365-1368, 1996.
11. Hatada, I., Ohashi, H., Fukushima, Y., Kaneko, Y., Inoue, M., Komoto, Y., Okada, A., Ohishi, S., Nabetani, A., Morisaki, H., Nakayama, M., Niikawa, N., and Mukai, T. An imprinted gene p57KIP2 is mutated in Beckwith Wiedemann syndrome. Nat. Genet., 14: 171-173, 1996.
12. Zhang, P., Liegeois, N. J., Wong, C., Finegold, M., Hou, H., Thompson, J. C., Silverman, A., Harper, J. W., DePinho, R. A., and Elledge, S. J. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature (Lond.), 387: 151-158, 1997.
13. Yan, Y., Frisen, J., Lee, M-H., Massagué, J., and Barbacid, M. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev., 11: 973-983, 1997.
14. Lee, M-H., Reynisdottir, I., and Massague, J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev., 9: 639-649, 1995.
15. Dynlacht, B. D., Ngwu, C., Winston, J., Swindell, E. C., Elledge, S. J., Harlow, E., and Harper, J. W. Purification and analysis of CIP/KIP proteins. Methods Enzymol., 283: 230-244, 1997.
16. Stampfer, M., and Yaswen, P. Culture systems for study of human mammary epithelial cell proliferation, differentiation and transformation. In: J. Taylor-Papadimitriou (ed.). Cancer Surveys, Vol. 18: Breast Cancer, pp. 7-34. Cold spring Harbor, NY: Cold Spring Harbor Laboratory, 1994.
17. Stampfer, M. R., and Bartley, J. C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo(a)pyrene. Proc. Natl. Acad. Sci. USA, 82: 2394-2398, 1985.
18. Walen, K., and Stampfer, M. R. Chromosome analyses of human mammary epithelial cells at stages of chemically-induced transformation progression to immortality. Cancer Genet. Cytogenet., 37: 249-261, 1989.
19. Lehman, T., Modali, R., Boukamp, P., Stanek, J., Bennett, W., Welsh, J., Metcalf, R., Stampfer, M., Fusenig, N., Rogan, E., Reddel, R., and Harris, C. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis (Lond.), 14: 833-839, 1993.
20. Sandhu, C., Garbe, J., Bhattacharya, N., Daksis, J. I., Pan, C-H., Yaswen, P., Koh, J., Slingerland, J. M., and Stampfer, M. R. TGF-β stabilizes p15INK4B protein, increases p15INK4B/cdk4 complexes and inhibits cyclin D1-cdk4 association in human mammary epithelial cells. Mol. Cell. Biol., 17: 2458-2467, 1997.
21. Brenner, A. J., and Aldaz, C. M. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res., 55: 2892-2895, 1995.
22. Brenner, A. J., Stampfer, M. R., and Aldaz, C. M. Increased p16INK4a expression with onset of senescence of human mammary epithelial cells and extended growth capacity with inactivation. Oncogene, 17: 199-205, 1998.
23. Stampfer, M. R., Bodnar, A., Garbe, J., Wong, M., Pan, A., Villeponteau, B., and Yaswen, P. Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. Mol. Biol. Cell, 8: 2391-2405, 1997.
24. Hammond, S. L., Ham, R. G., and Stampfer, M. R. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc. Natl. Acad. Sci. USA, 81: 5435-5439, 1984.
25. Stampfer, M. R. Isolation and growth of human mammary epithelial cells. J. Tissue Culture Methods, 9: 107-116, 1985.
26. Stampfer, M. R. Cholera toxin stimulation of human mammary epithelial cells in culture. In Vitro (Rockville), 18: 531-537, 1982.
27. Stampfer, M. R., and Bartley, J. C. Human mammary epithelial cells in culture: differentiation and transformation. In: R. Dickson and M. Lippman (eds.), Breast Cancer: Cellular and Molecular Biology, pp. 1-24. Norwall, MA: Kluwer Academic Publishers, 1988.
28. Stampfer, M. R., Pan, C. H., Hosoda, J., Bartholomew, J., Mendelsohn, J., and Yaswen, P. Blockage of EGF receptor signal transduction causes reversible arrest of normal and transformed human mammary epithelial cells with synchronous reentry into the cell cycle. Exp. Cell Res., 208: 175-188, 1993.
29. Morgenstern, J. P., and Land, H., Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18: 3587-3596, 1990.
30. Miller, A. D., and Rosman, G. J., Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-990, 1989.
31. Finer, M. H., Dull, T. J., Qin, L., Farson, D., and Roberts, M. R. kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood, 83: 43-50, 1994.
32. Yaswen, P., Smoll, A., Peehl, D. M., Trask, D. K., Sager, R., and Stampfer, M. R. Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells. Proc. Natl. Acad. Sci. USA, 87: 7360-7364, 1990.
33. Garbe, J., Wong, M., Wigington, D., Yaswen, P., and Stampfer, M. R. Viral oncogenes accelerate conversion to immortality of cultured human mammary epithelial cells. Oncogene, 18: 2169-2180, 1999.
34. Prowse, K. R., and Greider, C. W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA, 92: 4818-4822, 1995.
35. Hecht, A., Strahl-Bolsinger, S., Grunstein, M., Spreading of transcriptional repressor SIR3 from telomeric heterochromatin. Nature (Lond.), 383: 92-95, 1996.
36. Aparicio, O. M., and Gottschling, D. E. Overcoming telomeric silencing: a transactivator competes to establish gene expression in a cell-cycle dependent way. Genes Dev., 8: 1133-1146, 1994.
37. Taniguchi, T., Okamoto, K., and Reeve, A. E. Human p57KIP2 defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour. Oncogene, 14: 1201-1206, 1997.